AIMS: In advanced human atherosclerotic plaques infiltrating T cells congregate at sites of plaque rupture. However, little is known about the systemic activation of circulating T cells in acute coronary syndromes as a prerequisite for recruitment to atherosclerotic lesions. METHODS AND RESULTS: As a measure for specific lymphocyte activation we analyzed IFN-gamma production of T cells after stimulation with a superantigen and expression of CXCR-3 and CCR-3 in patients with acute myocardial infarction (AMI), unstable angina (uAP) or stable angina (sAP). Furthermore, concentrations of the circulating cytokines interleukin (IL)-1, IL-6, IL-1beta, IL-12 p70 and RANTES that modify T cell function were measured. In uAP an increased Th1 and a decreased Th2 response was identified by enhanced interferon-gamma generation of T lymphocytes, increased levels of IL-1beta, IL-12 p70 and RANTES and decreased expression of CCR3. In AMI a systemic inflammatory reaction predominates with enhanced expression of the early activation marker CD69 on T lymphocytes and elevated levels of IL-6 and IL-10 that suppress Th1 activation. CONCLUSION: Interferon-gamma production of activated T cells in acute coronary syndromes may, therefore, be governed by the release of specific pro- and anti-lymphocyte activating cytokines.
AIMS: In advanced humanatherosclerotic plaques infiltrating T cells congregate at sites of plaque rupture. However, little is known about the systemic activation of circulating T cells in acute coronary syndromes as a prerequisite for recruitment to atherosclerotic lesions. METHODS AND RESULTS: As a measure for specific lymphocyte activation we analyzed IFN-gamma production of T cells after stimulation with a superantigen and expression of CXCR-3 and CCR-3 in patients with acute myocardial infarction (AMI), unstable angina (uAP) or stable angina (sAP). Furthermore, concentrations of the circulating cytokines interleukin (IL)-1, IL-6, IL-1beta, IL-12 p70 and RANTES that modify T cell function were measured. In uAP an increased Th1 and a decreased Th2 response was identified by enhanced interferon-gamma generation of T lymphocytes, increased levels of IL-1beta, IL-12 p70 and RANTES and decreased expression of CCR3. In AMI a systemic inflammatory reaction predominates with enhanced expression of the early activation marker CD69 on T lymphocytes and elevated levels of IL-6 and IL-10 that suppress Th1 activation. CONCLUSION:Interferon-gamma production of activated T cells in acute coronary syndromes may, therefore, be governed by the release of specific pro- and anti-lymphocyte activating cytokines.
Authors: Jon R Ward; Sheila E Francis; Luke Marsden; Tesha Suddason; Graham M Lord; Steven K Dower; David C Crossman; Ian Sabroe Journal: Immunology Date: 2009-09 Impact factor: 7.397
Authors: Oliver Husser; Vicente Bodi; Juan Sanchis; Julio Nunez; Luis Mainar; Francisco Javier Chorro; Maria Pilar Lopez-Lereu; Jose Vicente Monmeneu; Fabian Chaustre; Maria J Forteza; Isabel Trapero; Francisco Dasi; Isabel Benet; Günter A J Riegger; Angel Llacer Journal: Inflammation Date: 2011-04 Impact factor: 4.092
Authors: Silke Mühlstedt; Santhosh K Ghadge; Johan Duchene; Fatimunnisa Qadri; Anne Järve; Larisa Vilianovich; Elena Popova; Andreas Pohlmann; Thoralf Niendorf; Philipp Boyé; Cemil Özcelik; Michael Bader Journal: J Mol Med (Berl) Date: 2016-06-01 Impact factor: 4.599